Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04989972

Organisation Name: Wake Network, Inc.

Overal Status: Withdrawn

Start Date: September 15, 2022

Last Update: June 30, 2022

Lead Sponsor: Wake Network, Inc.

Brief Summary: To investigate the efficacy of a 16 week treatment with PSIL428 patient reported anxiety levels in otherwise healthy individuals suffering from depression and or anxiety symptoms.

Conditions:
  • Anxiety and Depression


Total execution time in seconds: 0.42297697067261